Ronald M. MD Kurtz - Feb 10, 2023 Form 4 Insider Report for RxSight, Inc. (RXST)

Role
President & CEO, Director
Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Stock symbol
RXST
Transactions as of
Feb 10, 2023
Transactions value $
$500,000
Form type
4
Date filed
2/13/2023, 05:19 PM
Previous filing
Aug 5, 2021
Next filing
Mar 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Award $500K +40K $12.50 40K Feb 10, 2023 Direct
holding RXST Common Stock 930K Feb 10, 2023 See footnore F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 125,000 shares reported as directly held by the Reporting Person in previous Form 4 filings.
F2 Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.

Remarks:

President & Chief Executive Officer